Adrenal tumor - Wikipedia
Tumor markers
Molecular markers and the pathogenesis of adrenocortical cancer. | Semantic Scholar
Adrenal medulla development and medullary-cortical interactions - ScienceDirect
Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
Adrenal Incidentaloma: Practice Essentials, Anatomy, Pathophysiology
Frontiers | Adrenocortical Tumors and Pheochromocytoma/Paraganglioma Initially Mistaken as Neuroblastoma—Experiences From the GPOH-MET Registry
PDF) Chapter 4 CLINICAL USE OF TUMOR MARKERS
The Incidentally Discovered Adrenal Mass | NEJM
How to Differentiate Benign from Malignant Adrenocortical Tumors?
بسم الله الرحمن الرحيم. - ppt video online download
European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors in: European Journal of Endocrinology
Oncology
Stem cells, evolutionary aspects and pathology of the adrenal medulla: A new developmental paradigm - ScienceDirect
Overview of the 2022 WHO Classification of Adrenal Cortical Tumors | SpringerLink
Isolation and characterization of adrenocortical progenitors involved in the adaptation to stress | PNAS
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
Contemporary Review of Large Adrenal Tumors in a Tertiary Referral Center | Anticancer Research
Retinoic acid receptor α as a novel contributor to adrenal cortex structure and function through interactions with Wnt and Vegfa signalling | Scientific Reports
Cancers | Free Full-Text | Adjuvant Therapy in Adrenocortical Carcinoma: Reflections and Future Directions
Tumor Markers
Management of incidental adrenal tumours | The BMJ
Oncology
